Document is current

Article History

Received: 4 August 2025

Revised: 23 September 2025

Accepted: 6 October 2025

First Online: 16 October 2025

Declarations

:

: This work is exempt from formal oversight by our Institutional Review Board because this improvement project does not meet the definition of research with human subjects or a clinical investigation. No protected health information was collected, and this work is compliant with the Health Insurance Portability and Accountability Act. Informed consent was not relevant. This work was performed in accordance with the ethical standards stated in the 1964 Declaration of Helsinki.

: Authors AKG and WLD have no financial or non-financial conflict of interest. Author AHM serves as Chair of the American College of Radiology Board of Chancellors, Board Member of the Southeastern Angiographic Society, and Chair of Data Safety Monitoring Boards for FDA-approved clinical trials of (1) Penumbra and (2) Endologix. Further, AHM is an independent data reviewer for an FDA-approved trial for Boston Scientific Corporation, serves as a speaker for Cook Medical, and is a stockholder of (1) Senzime and (2) BrightWater Medical. Author CMG has received a research grant and served as a consultant for Philips and received publishing royalties from Oxford University Press and Thieme Medical Publishers. Further, CMG serves as Executive Vice Chair for Clinical Operations and Informatics for the Department of Radiology and Medical Imaging and as Chief Medical Imaging Information Officer for UVA Health.